At the news
? NEUTRALIMPACT 2/10 144 filed May 14, 2026 at 17:28 ET
Gregory Norden, an officer of Royalty Pharma, filed a Form 144 on May 14, 2026, indicating intent to sell 3,045 shares of common stock with an approximate market value of $161,385. The shares were acquired via vesting of restricted stock units on May 13, 2026, and the sale is a routine, small-dollar transaction relative to the company's $30.7B market cap.
- Filer: Gregory Norden (officer of Royalty Pharma)
- Proposed sale: 3,045 shares of common stock
- Approximate value: $161,385 (based on filing date price)
- Shares acquired via RSU vesting on May 13, 2026
Before · The news · First close · A day later · A week later
Replay the market's reaction
Step through every 5 minutes around the news, then see how it compares with similar events.
Subscribe for Full Access